A RANDOMIZED TRIAL OF MITOMYCIN/IFOSFAMIDE/CISPLATIN PREOPERATIVE CHEMOTHERAPY PLUS SURGERY VERSUS SURGERY ALONE IN STAGE IIIA NONSMALL CELL LUNG-CANCER

被引：0
|
作者：
ROSELL, R
MAESTRE, J
FONT, A
MORENO, I
MILLA, A
GOMEZCODINA, J
CAMPS, C
MOLINA, F
机构：
[1] UNIV BARCELONA, HOSP BADALONA GERMANS & PUJOL, DEPT THORAC SURG, E-08916 BARCELONA, SPAIN
[2] PLATON CLIN, DEPT RADIOTHERAPY, BARCELONA, SPAIN
[3] HOSP LA FE, DEPT MED ONCOL, VALENCIA, SPAIN
[4] HOSP GEN VALENCIA, DEPT MED ONCOL, VALENCIA, SPAIN
来源：
SEMINARS IN ONCOLOGY | 1994年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 33
页数：6
相关论文
共 50 条
  • [31] NEOADJUVANT CISPLATIN AND ETOPOSIDE FOR STAGE IIIA (CLINICAL N2) NONSMALL CELL LUNG-CANCER
    DARWISH, S
    MINOTTI, V
    CRINO, L
    ROSSETTI, R
    MARANZANO, E
    CHECCAGLINI, F
    FIASCHINI, P
    MERCATI, U
    PENZA, O
    VITALI, R
    DAVIS, S
    LATINI, P
    TONATO, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (01): : 64 - 67
  • [32] COMBINATION CHEMOTHERAPY WITH VINORELBINE, IFOSFAMIDE, AND CISPLATIN - A PHASE-II STUDY IN STAGE IIIB-IV NONSMALL CELL LUNG-CANCER
    BALDINI, E
    TIBALDI, C
    CHELLA, A
    ANGELETTI, CA
    ROMANINI, A
    ANDREI, A
    ALGERI, R
    SILVANO, G
    CONTE, PF
    SEMINARS IN ONCOLOGY, 1994, 21 (03) : 12 - 15
  • [33] A trial of combination chemotherapy of MIC (mitomycin C plus ifosfamide plus cisplatin) for stage IIIb and IV patients suffering from non small cell lung cancer
    Papadakis, EM
    Blazoyannakis, G
    Aggelidou, A
    Vossos, A
    Grivas, O
    Sinefaki, E
    Angeletopoulou, H
    Lampaditis, I
    Dimadi, M
    Vlastos, F
    Vesslemes, M
    Mavromanolakis, M
    Vlahonikolis, J
    Tzannes, S
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 441 - 444
  • [34] IFOSFAMIDE/CARBOPLATIN/ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH METASTATIC NONSMALL CELL LUNG-CANCER
    CHANG, AY
    ASBURY, RF
    BOROS, L
    GARROW, GC
    HSIEH, S
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 9 - 12
  • [35] INDUCTION CHEMOTHERAPY FOR STAGE-IIIA UNRESECTABLE NONSMALL CELL LUNG-CANCER - THE TORONTO EXPERIENCE AND AN OVERVIEW
    GOLDBERG, M
    BURKES, RL
    SEMINARS IN SURGICAL ONCOLOGY, 1993, 9 (02): : 108 - 113
  • [36] A RANDOMIZED TRIAL IN INOPERABLE NON-SMALL-CELL LUNG-CANCER - VINDESINE AND CISPLATIN VERSUS MITOMYCIN, VINDESINE, AND CISPLATIN VERSUS ETOPOSIDE AND CISPLATIN VERSUS ETOPOSIDE AND CISPLATIN ALTERNATING WITH VINDESINE AND MITOMYCIN
    FUKUOKA, M
    MASUDA, N
    FURUSE, K
    NEGORO, S
    TAKADA, M
    MATSUI, K
    TAKIFUJI, N
    KUDOH, S
    KAWAHARA, M
    OGAWARA, M
    KODAMA, N
    KUBOTA, K
    YAMAMOTO, M
    KUSUNOKI, Y
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) : 606 - 613
  • [37] A RANDOMIZED TRIAL OF 2 CISPLATIN-CONTAINING CHEMOTHERAPY REGIMENS IN PATIENTS WITH STAGE-III-B AND STAGE-IV NONSMALL CELL LUNG-CANCER
    ERKISI, M
    DORAN, F
    BURGUT, R
    KOCABAS, A
    LUNG CANCER, 1995, 12 (03) : 237 - 246
  • [38] COMBINATION CHEMOTHERAPY (C/T) WITH MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN ADVANCED NON-SMALL CELL LUNG-CANCER
    MILES, DW
    EARL, HM
    DRAKE, J
    CURRIE, DC
    SPIRO, SG
    SOUHAMI, RL
    HARPER, PG
    TOBIAS, JS
    BRITISH JOURNAL OF CANCER, 1990, 61 (01) : 183 - 184
  • [39] A RANDOMIZED TRIAL OF MACC CHEMOTHERAPY WITH OR WITHOUT LONIDAMINE IN ADVANCED NONSMALL CELL LUNG-CANCER
    BUCCHERI, G
    FERRIGNO, D
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) : 1424 - 1431
  • [40] A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209)
    Nagai, K
    Tsuchiya, R
    Mori, T
    Tada, H
    Ichinose, Y
    Koike, T
    Kato, H
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (02) : 254 - 260
12345